Co-Author: Vandana Priya – ConcertAI
### @@@ Urvashi Bhattacharyya, PhD – ConcertAI ### 2325650###Co-Author###Lead Data Scientist###ConcertAI###Co-Author: Urvashi Bhattacharyya, PhD – ConcertAI
### @@@ Sheenu Chandwani – ConcertAI ### 2325651###Co-Author######ConcertAI###Co-Author: Sheenu Chandwani – ConcertAI
### @@@ Herman E. Ray, PhD – ConcertAI ### 2325652###Co-Author###Contractor###ConcertAI###Co-Author: Herman E. Ray, PhD – ConcertAI
### @@@ Srikanth Tankala – ConcertAI ### 2325653###Co-Author######ConcertAI###Co-Author: Srikanth Tankala – ConcertAI
### @@@ Jake Cohen – ConcertAI ### 2325654###Co-Author######ConcertAI###Co-Author: Jake Cohen – ConcertAI
### @@@ Vivek Vaidya (he/him/his) – ConcertAI ### 2325655###Presenting Author###Executive Director - Predictive AI & Visual NLP###ConcertAI###Presenting Author: Vivek Vaidya (he/him/his) – ConcertAI
### he/him/hisPresenting Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ Ivonne Martin – 2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands ### 2325487###Co-Author######2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands###Co-Author: Ivonne Martin – 2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1655571###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Author: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers @@@ Svetlana V. Belitser – 4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands ### 1655669###Co-Author######4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands###Co-Author: Svetlana V. Belitser – 4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
### @@@ Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. ### 1991140###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.###Co-Author: Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.
### @@@ Elisa Correcher-Martinez – 5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991142###Co-Author######5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Elisa Correcher-Martinez – 5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Arantxa Urchueguía-Fornes, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991141###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###Co-Author: Arantxa Urchueguía-Fornes, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS) ### 1359445###Co-Author###Pharmacoepidemiologist###Spanish Agency of Medicines and Medical Devices (AEMPS)###Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)
### @@@ Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1655701###Co-Author######Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain###Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Meritxell Pallejà-Millán – 8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360561###Co-Author######8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Meritxell Pallejà-Millán – 8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Elena Segundo, n/a – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991143###Co-Author######Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Elena Segundo, n/a – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain. ### 1657346###Co-Author###Medical Writer###Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.###Co-Author: Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.
### @@@ Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht ### 1655741###Co-Author###Assistant Professor###Department of Data Science and Biostatistics, University Medical Center Utrecht###Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine###Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine
###Moderator: Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Moderator###Associate Professor###University of North Carolina at Chapel Hill###Moderator: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hersCo-Author: Sidse Marie Neumann Nielsen – University of Copenhagen
### @@@ Maurizio Sessa, PharmD – Department of Drug Design and Pharmacology, University of Copenhagen ### 1062857###Presenting Author###Associate Professor###Department of Drug Design and Pharmacology, University of Copenhagen###Presenting Author: Maurizio Sessa, PharmD – Department of Drug Design and Pharmacology, University of Copenhagen
###Presenting Author: Kate W. Gillespie, MPH PhD (she/her/hers) – Institute for Health Metrics and Evaluation (IHME)
### she/her/hers @@@ Assaf P. Oron, PhD (they/them/theirs) – University of Washington ### 2325719### Co-Author###Senior Analyst###University of Washington###Co-Author: Assaf P. Oron, PhD (they/them/theirs) – University of Washington
### they/them/theirs @@@ Parkes Kendrick – University of Washington ### 2325720###Co-Author######University of Washington###Co-Author: Parkes Kendrick – University of Washington
### @@@ Jiali Lei, MTM – Institute for Health Metrics and Evaluation, University of Washington ### 2325424###Co-Author###Analyst, Client Services###Institute for Health Metrics and Evaluation, University of Washington###Co-Author: Jiali Lei, MTM – Institute for Health Metrics and Evaluation, University of Washington
### @@@ Charles Jonscher, PhD – University of Washington ### 2325721###Co-Author######University of Washington###Co-Author: Charles Jonscher, PhD – University of Washington
### @@@ Greg A. Roth, MD – University of Washington ### 2325722###Co-Author######University of Washington###Co-Author: Greg A. Roth, MD – University of Washington
### @@@ Eliseo J. Perez-Stable, MD – National Institutes of Health ### 2325723###Co-Author######National Institutes of Health###Co-Author: Eliseo J. Perez-Stable, MD – National Institutes of Health
### @@@ George A. Mensah, MD – National Institutes of Health ### 2325724###Co-Author######National Institutes of Health###Co-Author: George A. Mensah, MD – National Institutes of Health
### @@@ Ali Mokdad, PhD – University of Washington ### 2325725###Co-Author######University of Washington###Co-Author: Ali Mokdad, PhD – University of Washington
### @@@ Laura Dwyer-Lindgren, PhD – University of Washington ### 2325726###Co-Author######University of Washington###Co-Author: Laura Dwyer-Lindgren, PhD – University of Washington
###Presenting Author: Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill
### @@@ Virginia Pate, MS – University of North Carolina at Chapel Hill ### 1358426###Co-Author###Analyst###University of North Carolina at Chapel Hill###Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 1991568###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###Co-Author: John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics ### 1359686###Co-Author######University of North Carolina Gillings School of Global Public Health Department of Biostatistics###Co-Author: Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisPresenting Author: Maria C. Schneeweiss, MD – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital ### 1302713###Co-Author###Professor###Brigham and Women's Hospital###Co-Author: Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital
### @@@ Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital ### 1655514###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital###Co-Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital
### @@@ Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062667###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Arash Mostaghimi, MD, MPA, MPH – Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School ### 1397912###Co-Author######Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Arash Mostaghimi, MD, MPA, MPH – Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School
### @@@ Joseph Merola, MD – Dept of Dermatology, UT Southwestern ### 2325367###Co-Author######Dept of Dermatology, UT Southwestern###Co-Author: Joseph Merola, MD – Dept of Dermatology, UT Southwestern
### @@@ Jonathan Silverberg, MD, PhD, MPH – Dept of Dermatology, George Washington University ### 1397913###Co-Author######Dept of Dermatology, George Washington University###Co-Author: Jonathan Silverberg, MD, PhD, MPH – Dept of Dermatology, George Washington University
### @@@ David Rosmarin, MD – Dept of Dermatology, University of Indiana ### 2325368###Co-Author######Dept of Dermatology, University of Indiana###Co-Author: David Rosmarin, MD – Dept of Dermatology, University of Indiana
### @@@ Robert Sidbury, MD, MPH – Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital ### 2325369###Co-Author######Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital###Co-Author: Robert Sidbury, MD, MPH – Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/hisCo-Author: Kwan Hur, PhD – Veterans Health Administration
### @@@ Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration ### 1302728###Presenting Author###Investigator###Veterans Health Administration###Presenting Author: Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration
### @@@ Bharat Thakkar, MS – Veterans Health Administration ### 1657536###Co-Author######Veterans Health Administration###Co-Author: Bharat Thakkar, MS – Veterans Health Administration
### @@@ Lucy Pandey, MS – Veterans Health Administration ### 1657535###Co-Author######Veterans Health Administration###Co-Author: Lucy Pandey, MS – Veterans Health Administration
### @@@ Walid Gellad, MD – VA Pittsburgh Healthcare System ### 1992664###Co-Author######VA Pittsburgh Healthcare System###Co-Author: Walid Gellad, MD – VA Pittsburgh Healthcare System
### @@@ Peter Glassman, MBBS, MSc – Veterans Health Administration ### 1657543###Co-Author######Veterans Health Administration###Co-Author: Peter Glassman, MBBS, MSc – Veterans Health Administration
### @@@ Chester B. Good, MD, MPH – Veterans Health Administration ### 1359135###Co-Author######Veterans Health Administration###Co-Author: Chester B. Good, MD, MPH – Veterans Health Administration
### @@@ Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA ### 1659630###Co-Author###Director, Clinical Epidemiology Program###Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA###Co-Author: Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA
### @@@ Donald R. Miller, ScD – Veterans Health Administration ### 1991692###Co-Author###Professor and Health Scientist###Veterans Health Administration###Co-Author: Donald R. Miller, ScD – Veterans Health Administration
### @@@ Fran E. Cunningham, PharmD – Veterans Health Administration ### 1655509###Co-Author###Director, Center for Medication Safety###Veterans Health Administration###Co-Author: Fran E. Cunningham, PharmD – Veterans Health Administration
###Presenting Author: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Massimiliano Russo – The Ohio State University ### 2325679### Co-Author######The Ohio State University###Co-Author: Massimiliano Russo – The Ohio State University
###Presenting Author: Jeremy P. Brown, MSc, PhD – Harvard T.H. Chan School of Public Health
### @@@ Jennifer J. Yland – Harvard T.H. Chan School of Public Health ### 2325201###Co-Author######Harvard T.H. Chan School of Public Health###Co-Author: Jennifer J. Yland – Harvard T.H. Chan School of Public Health
### @@@ Paige Williams – Harvard T.H. Chan School of Public Health ### 2325202###Co-Author######Harvard T.H. Chan School of Public Health###Co-Author: Paige Williams – Harvard T.H. Chan School of Public Health
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
###Presenting Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea ### 1358469###Co-Author###PhD Student###School of Pharmacy, Sungkyunkwan University, Suwon, Korea###Co-Author: Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea
### @@@ Gihwan Bae – Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea ### 2325577###Co-Author######Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea###Co-Author: Gihwan Bae – Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
### @@@ Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea ### 1991610###Co-Author######Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea###Co-Author: Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine
### she/her/hers @@@ Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine ### 1659127###Co-Author###Director###Johnson and Johnson Innovative Medicine###Co-Author: Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Azza Shoaibi, PhD, MPH – Johnson & Johnson ### 1360292###Co-Author###Director###Johnson & Johnson###Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson
### @@@ Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine ### 1046837###Co-Author###Associate Director of Epidemiology###Johnson and Johnson Innovative Medicine###Co-Author: Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Luis Humberto Anaya-Velarde, MD, MSc – Johnson & Johnson Innovative Medicine ### 1993409###Co-Author###Director, Medical Safety Officer###Johnson & Johnson Innovative Medicine###Co-Author: Luis Humberto Anaya-Velarde, MD, MSc – Johnson & Johnson Innovative Medicine
### @@@ E. Claire Newbern, PhD, MPH – Johnson and Johnson Innovative Medicine ### 1991938###Co-Author###Director, Global Epidemiology###Johnson and Johnson Innovative Medicine###Co-Author: E. Claire Newbern, PhD, MPH – Johnson and Johnson Innovative Medicine
###Presenting Author: Andrew R. Weckstein – Aetion Inc.
### @@@ Vera Frajzyngier, PhD, MPH – Aetion ### 1991832###Co-Author###VP Scientific Research###Aetion###Co-Author: Vera Frajzyngier, PhD, MPH – Aetion
### @@@ Sarah Vititoe, MPH – Aetion ### 2325435###Co-Author######Aetion###Co-Author: Sarah Vititoe, MPH – Aetion
### @@@ Aidan Baglivo, BS – Aetion ### 1655637###Co-Author###Senior Analyst###Aetion###Co-Author: Aidan Baglivo, BS – Aetion
### @@@ Elisha Beebe, BA – Aetion ### 1691611###Co-Author###Research Analyst###Aetion###Co-Author: Elisha Beebe, BA – Aetion
### @@@ Priya Govil, BA – Aetion ### 1655431###Co-Author###Senior Analyst###Aetion###Co-Author: Priya Govil, BA – Aetion
### @@@ Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA ### 1062817###Co-Author###Senior Advisor###Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA###Co-Author: Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA
### @@@ Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration ### 1358505###Co-Author###Senior Epidemiologist###US Food and Drug Administration###Co-Author: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
### @@@ Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration ### 1358274###Co-Author######Office of Surveillance and Epidemiology, US Food and Drug Administration###Co-Author: Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration
### @@@ Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration ### 1358504###Co-Author###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, U.S. Food and Drug Administration###Co-Author: Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration
### @@@ Aloka Chakravarty, PhD, Mstat – Pfizer, Inc. ### 2325528###Co-Author###VP, Head of Enterprise RWE###Pfizer, Inc.###Co-Author: Aloka Chakravarty, PhD, Mstat – Pfizer, Inc.
### @@@ Tamar Lasky, PhD (she/her/hers) – Retired ### 2325357###Co-Author###Retired###Retired###Co-Author: Tamar Lasky, PhD (she/her/hers) – Retired
### she/her/hers @@@ Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Co-Author###VP/Head of Scientific Research + Analytics###Aetion, Inc.###Co-Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1093999###Co-Author###Chief Science Officer###Aetion, Inc.###Co-Author: Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hersCo-Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration
### @@@ Kathryn Matuska, BA – Acumen, LLC ### 1659336###Co-Author###Policy Lead###Acumen, LLC###Co-Author: Kathryn Matuska, BA – Acumen, LLC
### @@@ Rowan McEvoy, B.S. – Acumen, LLC ### 1991408###Presenting Author###Policy Lead###Acumen, LLC###Presenting Author: Rowan McEvoy, B.S. – Acumen, LLC
### @@@ Hector S. Izurieta, MD, PhD – US Food and Drug Administration ### 1659297###Co-Author###Associate Director, OVRR/CBER###US Food and Drug Administration###Co-Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
### @@@ Jessica R. Hervol, MPH – Acumen, LLC ### 2325148###Co-Author######Acumen, LLC###Co-Author: Jessica R. Hervol, MPH – Acumen, LLC
### @@@ Mikhail Menis, PharmD, MS (he/him/his) – Center for Biologics Evaluation and Research, Food and Drug Administration ### 1358507###Co-Author###Epidemiologist###Center for Biologics Evaluation and Research, Food and Drug Administration###Co-Author: Mikhail Menis, PharmD, MS (he/him/his) – Center for Biologics Evaluation and Research, Food and Drug Administration
### he/him/his @@@ Arnstein Lindaas, MA – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###Co-Author: Arnstein Lindaas, MA – Acumen, LLC
### @@@ Whitney Steele, PhD – Center for Biologics Evaluation and Research, U.S. Food and Drug Administration ### 1659334###Co-Author###Health Scientist###Center for Biologics Evaluation and Research, U.S. Food and Drug Administration###Co-Author: Whitney Steele, PhD – Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Michael Wernecke, BA (he/him/his) – Acumen, LLC ### 1358529###Co-Author###Senior Research Manager###Acumen, LLC###Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC
### he/him/his @@@ Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA ### 1358531###Co-Author######Centers for Medicare & Medicaid Services, Washington, DC, USA###Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
###Lead Speaker: Evie Merinopoulou, MSc – Cytel
### @@@ Alind Gupta, PhD – Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto ### 1991513###Speaker###Adjunct Lecturer###Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto###Speaker: Alind Gupta, PhD – Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto
### @@@ Alessandria Strübing, MSPH – Daiichi Sankyo Europe ### 2325686###Speaker###Director Global Oncology, RWE Lead###Daiichi Sankyo Europe###Speaker: Alessandria Strübing, MSPH – Daiichi Sankyo Europe
### @@@ Blythe Adamson, PhD, MPH – Flatiron Health ### 2325353###Speaker###Senior Principal Scientist###Flatiron Health###Speaker: Blythe Adamson, PhD, MPH – Flatiron Health
### @@@ Stephen Duffield, PhD – National Institute of Health and Care Excellence (NICE) ### 1655608###Speaker###Associate Director for Real-World Evidence Methods###National Institute of Health and Care Excellence (NICE)###Speaker: Stephen Duffield, PhD – National Institute of Health and Care Excellence (NICE)
###Presenting Author: Zheng Chang, PhD (he/him/his) – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### he/him/hisLead Speaker: Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands
### she/her/hers @@@ Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1062823###Speaker###Associate Professor###Brigham and Women's Hospital and Harvard Medical School###Speaker: Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School
###Presenting Author: Giorgio Limoncella – University of Florence, Florence, Italy
### @@@ Leonardo Grilli, PhD – University of Florence ### 1994256###Co-Author###Full professor of statistics###University of Florence###Co-Author: Leonardo Grilli, PhD – University of Florence
### @@@ Emanuela Dreassi – University of Florence ### 1994257###Co-Author###Full professor of Statistics###University of Florence###Co-Author: Emanuela Dreassi – University of Florence
### @@@ Carla Rampichini, PhD – University of Florence ### 1994258###Co-Author###Full professor of Statistics###University of Florence###Co-Author: Carla Rampichini, PhD – University of Florence
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Co-Author###Professor###McGill University###Co-Author: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/his @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hersLead Speaker: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
### @@@ Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark ### 1358115###Lead Speaker###Assistant professor###University of Southern Denmark###Lead Speaker: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark
### @@@ Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands ### 1086972###Speaker###Professor###Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands###Speaker: Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands
### @@@ Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Speaker###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###Speaker: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326851###Speaker###Professor###Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
###Lead Speaker: Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### he/him/his @@@ Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine ### 1360173###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###Speaker: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Speaker###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Speaker: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hersLead Speaker: Vanessa Didelez, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1397900###Speaker###Statistician, postdoctoral research fellow###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Speaker: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Claudia Börnhorst, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 2328477###Speaker###Senior Researcher###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Speaker: Claudia Börnhorst, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###Lead Speaker: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Darmendra Ramcharran, PhD – GSK ### 1994710###Speaker###Sr Director, Safety & Quantitative Innovation###GSK###Speaker: Darmendra Ramcharran, PhD – GSK
### @@@ Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Speaker###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###Speaker: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Oskar Gauffin, MSc (he/him/his) – Uppsala Monitoring Centre ### 1358942###Speaker###Data Scientist###Uppsala Monitoring Centre###Speaker: Oskar Gauffin, MSc (he/him/his) – Uppsala Monitoring Centre
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Speaker###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Speaker: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Speaker###Professor###University of Southern Denmark###Speaker: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital ### 1062628###Speaker###Senior Pharmacist Educator###Keelung Chang Gung Memorial Hospital###Speaker: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital
### @@@ Weny Huang – Taiwan National Adverse Drug Reaction Reporting Center/ Taiwan Drug Relief Foundation ### 1360456###Speaker######Taiwan National Adverse Drug Reaction Reporting Center/ Taiwan Drug Relief Foundation###Speaker: Weny Huang – Taiwan National Adverse Drug Reaction Reporting Center/ Taiwan Drug Relief Foundation
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Speaker###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Speaker: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/hisPresenting Author: Morgane Swital, MSc – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM) ### 1993521###Co-Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###Co-Author: Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM)
### @@@ Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360499###Co-Author###PhD, PharmD, MPH###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###Presenting Author: Tianyi Wang, PhD (she/her/hers) – Janssen Research & Development LLC.
### she/her/hers @@@ Dinorah J. Villanueva, MS, MBA – Janssen Research & Development LLC. ### 2325137###Co-Author###Associate Director, DEICT Process Lead###Janssen Research & Development LLC.###Co-Author: Dinorah J. Villanueva, MS, MBA – Janssen Research & Development LLC.
### @@@ Dina Gifkins – Janssen Research & Development, LLC ### 1658381###Co-Author###Senior Director, Global Epidemiology###Janssen Research & Development, LLC###Co-Author: Dina Gifkins – Janssen Research & Development, LLC
###Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Victoria Strauss, PhD – Boehringer Ingelheim ### 1992049###Speaker###Senior Principle TA methodology statistician###Boehringer Ingelheim###Speaker: Victoria Strauss, PhD – Boehringer Ingelheim
### @@@ Joseph W. Zabinski, PhD – OM1, Inc. ### 1653785###Speaker###VP, AI###OM1, Inc.###Speaker: Joseph W. Zabinski, PhD – OM1, Inc.
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Speaker###Associate Director of Epidemiology###IQVIA###Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hersSpeaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
### @@@ Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Speaker###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###Speaker: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hersPresenting Author: Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science
### he/him/his @@@ Abner Nyandege, PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1359571###Co-Author######Rutgers Center for Pharmacoepidemiology and Treatment Science###Co-Author: Abner Nyandege, PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Edward Nonnenmache – Bayshore Analytics and Integrated Solutions LLC ### 2325432###Co-Author######Bayshore Analytics and Integrated Solutions LLC###Co-Author: Edward Nonnenmache – Bayshore Analytics and Integrated Solutions LLC
### @@@ Jason A. Roy, PhD – Rutgers School of Public Health ### 1360415###Co-Author###Professor of Biostatistics and Epidemiology###Rutgers School of Public Health###Co-Author: Jason A. Roy, PhD – Rutgers School of Public Health
### @@@ Kirk Benack – Montefiore Medical Center ### 2325433###Co-Author######Montefiore Medical Center###Co-Author: Kirk Benack – Montefiore Medical Center
### @@@ Saira Jan, MS, Pharm.D. – Horizon Blue Cross Blue Shield of New Jersey ### 1359574###Co-Author###Vice President and Chief Pharmacy Officer###Horizon Blue Cross Blue Shield of New Jersey###Co-Author: Saira Jan, MS, Pharm.D. – Horizon Blue Cross Blue Shield of New Jersey
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Co-Author###Professor of Medicine and Epidemiology###Rutgers University###Co-Author: Soko Setoguchi, MD, DrPH – Rutgers University
### @@@ Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research ### 1046831###Co-Author###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research###Co-Author: Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research
### he/him/his @@@ Brian L. Strom, MD, MPH (he/him/his) – Rutgers, State University of New Jersey ### 1302723###Co-Author###Chancellor, Biomedical and Health Sciences###Rutgers, State University of New Jersey###Co-Author: Brian L. Strom, MD, MPH (he/him/his) – Rutgers, State University of New Jersey
### he/him/hisPresenting Author: Yueh-Yi Chiang, BSPharm (she/her/hers) – University of Maryland School of Pharmacy
### she/her/hers @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy###Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy
###Presenting Author: João Paulo Fernandes – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
### @@@ Pedro Benjamim – MD Clinical Pharmacology Unit, Santa Maria Local Health Unit, Lisbon,Portugal ### 2325658###Co-Author######MD Clinical Pharmacology Unit, Santa Maria Local Health Unit, Lisbon,Portugal###Co-Author: Pedro Benjamim – MD Clinical Pharmacology Unit, Santa Maria Local Health Unit, Lisbon,Portugal
### @@@ Márcia Silva – INFARMED, I.P. - Autoridade Nacional do Medicamento e Produtos de Saúde, Lisboa, Portugal ### 2325659###Co-Author######INFARMED, I.P. - Autoridade Nacional do Medicamento e Produtos de Saúde, Lisboa, Portugal###Co-Author: Márcia Silva – INFARMED, I.P. - Autoridade Nacional do Medicamento e Produtos de Saúde, Lisboa, Portugal
### @@@ Bruno Sepodes, PharmD, MSc, PhD, MPH – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1655923###Co-Author###Full Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###Co-Author: Bruno Sepodes, PharmD, MSc, PhD, MPH – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
### @@@ Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1359276###Co-Author###Assistant Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###Co-Author: Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
###Presenting Author: Juan Carlos JC Bazo-Alvarez, MSc – University College London
### @@@ Irene Petersen, PhD – University College London ### 1658084###Co-Author######University College London###Co-Author: Irene Petersen, PhD – University College London
###Lead Speaker: Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Jessica M. Franklin, PhD (she/her/hers) – Optum ### 1359343###Speaker###Principal Consultant###Optum###Speaker: Jessica M. Franklin, PhD (she/her/hers) – Optum
### she/her/hers @@@ Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325505###Speaker######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###Speaker: Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Marissa J. Seamans, PhD – University of California Los Angeles ### 1359410###Speaker###Assistant Professor###University of California Los Angeles###Speaker: Marissa J. Seamans, PhD – University of California Los Angeles
### @@@ Chao Cai, PhD (she/her/hers) – University of South Carolina ### 1994283###Speaker###Assistant Professor###University of South Carolina###Speaker: Chao Cai, PhD (she/her/hers) – University of South Carolina
### she/her/hers @@@ Ellen (Feng-Hua) Loh, PhD – Touro University ### 1445421###Speaker###Assistant Professor###Touro University###Speaker: Ellen (Feng-Hua) Loh, PhD – Touro University
###Lead Speaker: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Speaker###VP/Head of Scientific Research + Analytics###Aetion, Inc.###Speaker: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hersPresenting Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK ### 1991261###Co-Author###Vice President###Analysis Group, Inc., London, UK###Co-Author: Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK
### she/her/hers @@@ Kieran J. Rothnie, PhD – GSK ### 1062865###Co-Author###Director Epidemiology###GSK###Co-Author: Kieran J. Rothnie, PhD – GSK
### @@@ Stephen Evans – London School of Hygiene and Tropical Medicine ### 2328409###Co-Author######London School of Hygiene and Tropical Medicine###Co-Author: Stephen Evans – London School of Hygiene and Tropical Medicine
### @@@ Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine###Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine
###Presenting Author: Catherine Vasilakis-Scaramozza, PhD (she/her/hers) – BCDSP
### she/her/hers @@@ Rebecca Persson, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program ### 1657756###Co-Author###Epidemiologist###Boston Collaborative Drug Surveillance Program###Co-Author: Rebecca Persson, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program
### she/her/hers @@@ George Kafatos, MSc PhD CStat – Amgen ### 1657757###Co-Author###Observational Research Director###Amgen###Co-Author: George Kafatos, MSc PhD CStat – Amgen
### @@@ David E. Neasham, PhD – Amgen Ltd ### 1657758###Co-Author###Senior Manager###Amgen Ltd###Co-Author: David E. Neasham, PhD – Amgen Ltd
### @@@ Katrina Wilcox Hagberg, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program ### 1062956###Co-Author###Senior Epidemiologist###Boston Collaborative Drug Surveillance Program###Co-Author: Katrina Wilcox Hagberg, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program
### she/her/hers @@@ Susan Jick, DSc – Boston Collaborative Drug Surveillance Program ### 1358051###Co-Author###DIrector###Boston Collaborative Drug Surveillance Program###Co-Author: Susan Jick, DSc – Boston Collaborative Drug Surveillance Program
###Moderator: Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania
### he/him/his @@@ Hilda Duran, MPH, MD, MSc (she/her/hers) – La Salle University ### 2406737###Moderator###Scientist###La Salle University###Moderator: Hilda Duran, MPH, MD, MSc (she/her/hers) – La Salle University
### she/her/hersCo-Author: Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht ### 1655741###Co-Author###Assistant Professor###Department of Data Science and Biostatistics, University Medical Center Utrecht###Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht
### @@@ Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands ### 1991418###Co-Author###PhD candidate###Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands###Co-Author: Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands
### @@@ Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1655701###Co-Author######Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain###Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS) ### 1359445###Co-Author###Pharmacoepidemiologist###Spanish Agency of Medicines and Medical Devices (AEMPS)###Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)
### @@@ Olga Paoletti – ARS Toscana ### 1359270###Co-Author###Researcher###ARS Toscana###Co-Author: Olga Paoletti – ARS Toscana
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. ### 1991140###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.###Co-Author: Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.
### @@@ Ainara Mira, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. ### 1360557###Co-Author###Senior biostatistician###Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.###Co-Author: Ainara Mira, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.
### @@@ Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain. ### 1657346###Co-Author###Medical Writer###Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.###Co-Author: Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Presenting Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Presenting Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hersCo-Author: Dana J. Murdock, MPH, PhD – Regeneron Pharmaceuticals, Inc.
### @@@ Li Wang – Regeneron Pharmaceuticals, Inc. ### 2325582###Co-Author######Regeneron Pharmaceuticals, Inc.###Co-Author: Li Wang – Regeneron Pharmaceuticals, Inc.
### @@@ Robert Sanchez – Regeneron Pharmaceuticals, Inc. ### 1992243###Co-Author######Regeneron Pharmaceuticals, Inc.###Co-Author: Robert Sanchez – Regeneron Pharmaceuticals, Inc.
### @@@ Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Co-Author###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###Co-Author: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Kusha Mohammadi – Regeneron Pharmaceuticals, Inc. ### 2325583###Co-Author######Regeneron Pharmaceuticals, Inc.###Co-Author: Kusha Mohammadi – Regeneron Pharmaceuticals, Inc.
### @@@ Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc. ### 1360060###Co-Author######Regeneron Pharmaceuticals, Inc.###Co-Author: Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc.
### @@@ Sergio Fazio – Regeneron Pharmaceuticals, Inc. ### 2325584###Co-Author######Regeneron Pharmaceuticals, Inc.###Co-Author: Sergio Fazio – Regeneron Pharmaceuticals, Inc.
### @@@ Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1062874###Presenting Author###Executive Director###Regeneron Pharmaceuticals, Inc.###Presenting Author: Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hersPresenting Author: Xinyue Liu, PhD – Epidemiology, Merck & Co., Inc.
### @@@ Tianchen Lyu – Health Outcomes & Biomedical informatics, University of Florida ### 2330965###Co-Author######Health Outcomes & Biomedical informatics, University of Florida###Co-Author: Tianchen Lyu – Health Outcomes & Biomedical informatics, University of Florida
### @@@ Xing He – Health Outcomes & Biomedical informatics, University of Florida ### 2330966###Co-Author######Health Outcomes & Biomedical informatics, University of Florida###Co-Author: Xing He – Health Outcomes & Biomedical informatics, University of Florida
### @@@ Lihai Song – Biostatistics and Research Decision Sciences, Merck & Co., Inc. ### 2330967###Co-Author######Biostatistics and Research Decision Sciences, Merck & Co., Inc.###Co-Author: Lihai Song – Biostatistics and Research Decision Sciences, Merck & Co., Inc.
### @@@ Edward Bortnichak – Epidemiology, Merck & Co. Inc. ### 2330968###Co-Author######Epidemiology, Merck & Co. Inc.###Co-Author: Edward Bortnichak – Epidemiology, Merck & Co. Inc.
### @@@ Jiang Bian, PhD – College of Medicine, University of Florida ### 1658680###Co-Author###Professor, Health Outcomes & Biomedical Informatics###College of Medicine, University of Florida###Co-Author: Jiang Bian, PhD – College of Medicine, University of Florida
###Presenting Author: Catherine Callahan, PhD, MA (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration
### she/her/hers @@@ Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325162###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###Co-Author: Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Kimberly Barrett – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325635###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: Kimberly Barrett – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Derek Campbell – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325636###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: Derek Campbell – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Kira Leishear, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 1655537###Co-Author###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration###Co-Author: Kira Leishear, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration
### @@@ Carrie Ceresa – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 2325638###Co-Author######Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration###Co-Author: Carrie Ceresa – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration
### @@@ Miriam Dinatale – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 2325639###Co-Author######Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration###Co-Author: Miriam Dinatale – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration
###Co-Author: Xiangyu (Chianti) Shi, MS – Acumen LLC
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Presenting Author###Epidemiologist###US FDA###Presenting Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Michelle Ondari, MSPH – Acumen LLC ### 1991411###Co-Author######Acumen LLC###Co-Author: Michelle Ondari, MSPH – Acumen LLC
### @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Pablo Freyria Duenas, MA – Acumen LLC ### 2325114###Co-Author######Acumen LLC###Co-Author: Pablo Freyria Duenas, MA – Acumen LLC
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC ### 2325538###Co-Author###Senior Policy Assoicate###Acumen, LLC###Co-Author: Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC
### @@@ Sylvia Cho, PhD – US FDA ### 2325116###Co-Author######US FDA###Co-Author: Sylvia Cho, PhD – US FDA
### @@@ Laurie Feinberg, MD – Acumen LLC ### 2325117###Co-Author######Acumen LLC###Co-Author: Laurie Feinberg, MD – Acumen LLC
### @@@ Mao I. Hu, BS – Acumen LLC ### 1655532###Co-Author###Policy Researcher###Acumen LLC###Co-Author: Mao I. Hu, BS – Acumen LLC
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA ### 1358531###Co-Author######Centers for Medicare & Medicaid Services, Washington, DC, USA###Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###Presenting Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Huei-Kai Huang, MD PhD (he/him/his) – Department of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan ### 2330061###Co-Author###Attending physician###Department of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan###Co-Author: Huei-Kai Huang, MD PhD (he/him/his) – Department of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
### he/him/his @@@ Peter Ping-Sung Liu, MS – Center for Healthy Longevity, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan. ### 2328367###Co-Author######Center for Healthy Longevity, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.###Co-Author: Peter Ping-Sung Liu, MS – Center for Healthy Longevity, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
### @@@ Tzu-Chi Liao, MS – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. ### 2327341###Co-Author######School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.###Co-Author: Tzu-Chi Liao, MS – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital ### 1062628###Co-Author###Senior Pharmacist Educator###Keelung Chang Gung Memorial Hospital###Co-Author: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/hisPresenting Author: Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Rachel C. Nethery, PhD – Harvard T.H. Chan School of Public Health ### 1359788###Co-Author###Assistant Professor of Biostatistics###Harvard T.H. Chan School of Public Health###Co-Author: Rachel C. Nethery, PhD – Harvard T.H. Chan School of Public Health
### @@@ Melanie Rua, PharmD, MPH – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1991270###Co-Author######Rutgers Center for Pharmacoepidemiology and Treatment Science###Co-Author: Melanie Rua, PharmD, MPH – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Hari Iyer, PhD – Rutgers Cancer Institute of New Jersey ### 2325641###Co-Author######Rutgers Cancer Institute of New Jersey###Co-Author: Hari Iyer, PhD – Rutgers Cancer Institute of New Jersey
### @@@ Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey ### 2325384###Co-Author######Rutgers Cancer Institute of New Jersey###Co-Author: Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Co-Author###Professor of Medicine and Epidemiology###Rutgers University###Co-Author: Soko Setoguchi, MD, DrPH – Rutgers University
###Co-Author: Ying Lu – University of Florida
### @@@ Huilin Tang, MS – University of Florida ### 1658671###Presenting Author###Predoctoral Fellowship###University of Florida###Presenting Author: Huilin Tang, MS – University of Florida
### @@@ William T Donahoo, MD – University of Florida ### 1360407###Co-Author######University of Florida###Co-Author: William T Donahoo, MD – University of Florida
### @@@ Jiang Bian, PhD – College of Medicine, University of Florida ### 1658680###Co-Author###Professor, Health Outcomes & Biomedical Informatics###College of Medicine, University of Florida###Co-Author: Jiang Bian, PhD – College of Medicine, University of Florida
### @@@ Jingchuan Guo, MD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1357944###Co-Author###Assistant Professor###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Jingchuan Guo, MD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
###Presenting Author: Anh Tran, BPharm, MSc (she/her/hers) – EPI-PHARE
### she/her/hers @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Jeanne SIBIUDE – IAME, INSERM ### 1993519###Co-Author######IAME, INSERM###Co-Author: Jeanne SIBIUDE – IAME, INSERM
### @@@ Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM) ### 1993521###Co-Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###Co-Author: Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Lise Marty, PhD – EPI-PHARE (ANSM/CNAM) ### 2325312###Co-Author###Biostatistician###EPI-PHARE (ANSM/CNAM)###Co-Author: Lise Marty, PhD – EPI-PHARE (ANSM/CNAM)
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Xavier Duval – IAME, INSERM ### 1993515###Co-Author######IAME, INSERM###Co-Author: Xavier Duval – IAME, INSERM
### @@@ Sarah Tubiana – IAME, INSERM ### 1993514###Co-Author######IAME, INSERM###Co-Author: Sarah Tubiana – IAME, INSERM
###Presenting Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Co-Author###Research fellow###National Cheng Kung University###Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/hisCo-Author: Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Xavier Muller – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France ### 2325506###Co-Author######Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France###Co-Author: Xavier Muller – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Health Data Department, Lyon, France ### 1991160###Presenting Author###Deputy head of the health data department of the Hospices Civils de Lyon###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Health Data Department, Lyon, France###Presenting Author: Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Health Data Department, Lyon, France
### @@@ Aurélie Moskal, PhD (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991154###Co-Author###Health Data Analyst###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###Co-Author: Aurélie Moskal, PhD (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### she/her/hers @@@ Stéphanie POLAZZI – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325507###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###Co-Author: Stéphanie POLAZZI – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Bruno CHARPIAT – Pharmacy Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France ### 2325508###Co-Author######Pharmacy Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France###Co-Author: Bruno CHARPIAT – Pharmacy Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
### @@@ Jean-Yves MABRUT – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France ### 2325509###Co-Author######Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France###Co-Author: Jean-Yves MABRUT – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Antoine DUCLOS – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325510###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###Co-Author: Antoine DUCLOS – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Mickaël LESURTEL – Department of HPB surgery and liver transplantation, AP-HP, Beaujon Hospital, DMU DIGEST, University of Paris Cité, Paris, France. ### 2325511###Co-Author######Department of HPB surgery and liver transplantation, AP-HP, Beaujon Hospital, DMU DIGEST, University of Paris Cité, Paris, France.###Co-Author: Mickaël LESURTEL – Department of HPB surgery and liver transplantation, AP-HP, Beaujon Hospital, DMU DIGEST, University of Paris Cité, Paris, France.
###Co-Author: Anne Bénard-Laribière – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France
### @@@ Elodie Pambrun – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France ### 1360544###Co-Author######Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France###Co-Author: Elodie Pambrun – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France
### @@@ Serge Kouzan – Pulmonary Department, Centre Regional Hospital, Chambery, France ### 2325391###Co-Author######Pulmonary Department, Centre Regional Hospital, Chambery, France###Co-Author: Serge Kouzan – Pulmonary Department, Centre Regional Hospital, Chambery, France
### @@@ Jean-Luc Faillie – Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France ### 1358928###Co-Author######Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France###Co-Author: Jean-Luc Faillie – Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France
### @@@ Julien Bezin – Univ. Bordeaux, INSERM, BPH, U1219, équipe AHeaD, Bordeaux (France); CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, Bordeaux (France) ### 1358001###Co-Author######Univ. Bordeaux, INSERM, BPH, U1219, équipe AHeaD, Bordeaux (France); CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, Bordeaux (France)###Co-Author: Julien Bezin – Univ. Bordeaux, INSERM, BPH, U1219, équipe AHeaD, Bordeaux (France); CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, Bordeaux (France)
### @@@ Antoine Pariente, MD, PhD – INSERM team AHeaD - Pharmacoepi & Beyond, Univ Bordeaux ### 1358005###Presenting Author###Professor of Pharmacology - Head of Public Health Department###INSERM team AHeaD - Pharmacoepi & Beyond, Univ Bordeaux###Presenting Author: Antoine Pariente, MD, PhD – INSERM team AHeaD - Pharmacoepi & Beyond, Univ Bordeaux
###Presenting Author: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
### @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Hilde M. Engjom, PhD – Norwegian Institute of Public Health ### 1659158###Co-Author###Specialist consultant and postdoctoral researcher###Norwegian Institute of Public Health###Co-Author: Hilde M. Engjom, PhD – Norwegian Institute of Public Health
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hersPresenting Author: Siu Chung Andrew Yuen, MPharm (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Co-Author###Lecturer/Assistant Professor###UCL School of Pharmacy###Co-Author: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/hisPresenting Author: Xi Xiong, Msc – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ David Lui – Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 2325370###Co-Author######Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong###Co-Author: David Lui – Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1991171###Co-Author###PhD Researcher###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###Co-Author: Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### he/him/his @@@ Ziyi Zhou – School of Health and Wellbeing, University of Glasgow ### 2325371###Co-Author######School of Health and Wellbeing, University of Glasgow###Co-Author: Ziyi Zhou – School of Health and Wellbeing, University of Glasgow
### @@@ Chao Xu – School of Health and Wellbeing, University of Glasgow ### 2325372###Co-Author######School of Health and Wellbeing, University of Glasgow###Co-Author: Chao Xu – School of Health and Wellbeing, University of Glasgow
### @@@ Paul Welsh – School of Cardiovascular and Metabolic Health, University of Glasgow ### 2325373###Co-Author######School of Cardiovascular and Metabolic Health, University of Glasgow###Co-Author: Paul Welsh – School of Cardiovascular and Metabolic Health, University of Glasgow
### @@@ Naveed Sattar – School of Cardiovascular and Metabolic Health, University of Glasgow ### 2325374###Co-Author######School of Cardiovascular and Metabolic Health, University of Glasgow###Co-Author: Naveed Sattar – School of Cardiovascular and Metabolic Health, University of Glasgow
### @@@ Carlos Celis-Morales – School of Health and Wellbeing, University of Glasgow ### 2325375###Co-Author######School of Health and Wellbeing, University of Glasgow###Co-Author: Carlos Celis-Morales – School of Health and Wellbeing, University of Glasgow
### @@@ Jill Pell – School of Health and Wellbeing, University of Glasgow ### 2325376###Co-Author######School of Health and Wellbeing, University of Glasgow###Co-Author: Jill Pell – School of Health and Wellbeing, University of Glasgow
### @@@ Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358232###Co-Author###Professor###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### he/him/his @@@ Carlos K. Wong – Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358585###Co-Author######Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong###Co-Author: Carlos K. Wong – Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Frederick Ho – School of Health and Wellbeing, University of Glasgow ### 2325377###Co-Author######School of Health and Wellbeing, University of Glasgow###Co-Author: Frederick Ho – School of Health and Wellbeing, University of Glasgow
###Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Speaker###Associate Professor of Medicine###Brigham and Women's Hospital and###Speaker: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers @@@ Jessica M. Franklin, PhD (she/her/hers) – Optum ### 1359343###Speaker###Principal Consultant###Optum###Speaker: Jessica M. Franklin, PhD (she/her/hers) – Optum
### she/her/hers @@@ Samy Suissa, PhD, FRSC, FCAHS – McGill University ### 1302854###Speaker###Distinguished James McGill Professor###McGill University###Speaker: Samy Suissa, PhD, FRSC, FCAHS – McGill University
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
###